Greg Norden

Greg Norden is the former Chief Financial Officer of Wyeth. In addition, Greg is the Managing Director of G9 Capital Group, LLC, which invests in early-stage ventures and provides corporate advisory services. Greg also serves on the Boards of Zoetis, the leading animal health company and Praxis, a clinical-stage biopharmaceutical company. Greg is a former director of Human Genome Sciences, Univision and Welch Allyn. Prior to his affiliation with Wyeth, Mr. Norden served as Audit Manager at Arthur Andersen & Co, working primarily with multinational companies in the life sciences, consumer goods and financial services industries. Greg has a BS in Management and Economics from State University of New York at Plattsburgh and an MS in Accounting from LIU Post.

Stay up to date

Subscribe to Royalty Pharma news and alerts

Subscribe